B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome
B cells are a major component of the tumour microenvironment, where they are
predominantly associated with tertiary lymphoid structures (TLS). In germinal centres within …
predominantly associated with tertiary lymphoid structures (TLS). In germinal centres within …
Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer
There is abundant evidence that tumor-infiltrating CD8+ T cells contribute positively to
antitumor immunity; however, the role of tumor-infiltrating B cells (TIL-B) and plasma cells …
antitumor immunity; however, the role of tumor-infiltrating B cells (TIL-B) and plasma cells …
Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer
Evidence indicates that lung cancer development is a complex process that involves
interactions between tumor cells, stromal fibroblasts, and immune cells. Tumor-infiltrating …
interactions between tumor cells, stromal fibroblasts, and immune cells. Tumor-infiltrating …
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
The clinical relevance of the host immune system in breast cancer has long been
unexplored. Studies developed over the past decade have highlighted the biological …
unexplored. Studies developed over the past decade have highlighted the biological …
[HTML][HTML] The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Evidence is strengthening for the morphological evaluation of tumor infiltrating lymphocytes
(TILs) in breast cancer. Herein, the concepts for TILs assessment are laid out by pathologists …
(TILs) in breast cancer. Herein, the concepts for TILs assessment are laid out by pathologists …
Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2–positive and triple …
C Denkert, G Von Minckwitz, JC Brase… - Journal of clinical …, 2015 - ascopubs.org
Purpose Modulation of immunologic interactions in cancer tissue is a promising therapeutic
strategy. To investigate the immunogenicity of human epidermal growth factor receptor 2 …
strategy. To investigate the immunogenicity of human epidermal growth factor receptor 2 …
High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype …
S Olbrecht, P Busschaert, J Qian, A Vanderstichele… - Genome Medicine, 2021 - Springer
Background High-grade serous tubo-ovarian cancer (HGSTOC) is characterised by
extensive inter-and intratumour heterogeneity, resulting in persistent therapeutic resistance …
extensive inter-and intratumour heterogeneity, resulting in persistent therapeutic resistance …
Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer
Abstract Purpose: CD8+ tumor-infiltrating lymphocytes (TIL) are key mediators of antitumor
immunity and are strongly associated with survival in virtually all solid tumors. However, the …
immunity and are strongly associated with survival in virtually all solid tumors. However, the …
Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance
Conventional chemotherapeutics and targeted antineoplastic agents have been developed
based on the simplistic notion that cancer constitutes a cell-autonomous genetic or …
based on the simplistic notion that cancer constitutes a cell-autonomous genetic or …
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
Multiple independent studies have shown that tumor-infiltrating lymphocytes (TIL) are
prognostic in breast cancer with potential relevance for response to immune-checkpoint …
prognostic in breast cancer with potential relevance for response to immune-checkpoint …